1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Pennsylvania >
  6. EmCyte Acquires Cellmedix Holdings

M&A Deal Summary

EmCyte Acquires Cellmedix Holdings

On February 20, 2020, EmCyte acquired life science company Cellmedix Holdings

Acquisition Highlights
  • This is EmCyte’s 1st transaction in the Life Science sector.
  • This is EmCyte’s 1st transaction in the United States.
  • This is EmCyte’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2020-02-20
Target Cellmedix Holdings
Sector Life Science
Buyer(s) EmCyte
Deal Type Add-on Acquisition

Target

Cellmedix Holdings

Milford, Pennsylvania, United States
Cellmedix Holdings LLC offers superior value with Centrepid System featuring exceptional flexibility and high platelet yields in a very cost-effective package.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

EmCyte

Fort Myers, Florida, United States
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

EmCyte Corp. engages in platelet-rich plasma and progenitor stem cell biologics with products that meet the highest achievable performance standard. EmCyte has remained committed to innovation that truly makes a clinical difference.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal